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Schiff bases, named after Hugo Schiff [1], are formed when any
primary amine reacts with an aldehyde or a ketone under spe-
ciﬁc conditions. Structurally, a Schiff base (also known as
imine or azomethine) (Fig. 1) is a nitrogen analogue of an alde-3409 6373; fax: +55 31 3409
(Aˆ. de Fa´tima).
Production and hosting by
o University.
lsevierhyde or ketone in which the carbonyl group (C‚O) has been
replaced by an imine or azomethine group.
Schiff bases are some of the most widely used organic com-
pounds. They are used as pigments and dyes, catalysts, inter-
mediates in organic synthesis, and as polymer stabilisers [2].
Schiff bases have also been shown to exhibit a broad range
of biological activities, including antifungal, antibacterial, anti-
malarial, antiproliferative, anti-inﬂammatory, antiviral, and
antipyretic properties [2,3]. Imine or azomethine groups are
present in various natural, natural-derived, and non-natural
compounds (see Fig. 2 for some examples). The imine group
present in such compounds has been shown to be critical to
their biological activities [4–6].
In this review we present the general approaches to the syn-
thesis of Schiff bases. We also highlight the most signiﬁcant
examples of compounds belonging to this class, which exhibit
antimalarial, antibacterial, antifungal, and/or antiviral activi-
ties to have been reported in the literature. The relationship be-
tween Schiff bases and other pharmacological activities, such
as antiproliferative activities, are not included in this review.
C N
R1 R3
R1, R2, and/or R3 = alkyl or aryl
R2
Fig. 1 General structure of a Schiff base.
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The ﬁrst preparation of imines was reported in the 19th cen-
tury by Schiff (1864). Since then a variety of methods for the
synthesis of imines have been described [7]. The classical syn-
thesis reported by Schiff involves the condensation of a car-
bonyl compound with an amine under azeotropic distillation
[8]. Molecular sieves are then used to completely remove water
formed in the system [9]. In the 1990s an in situ method for
water elimination was developed, using dehydrating solvents
such as tetramethyl orthosilicate or trimethyl orthoformate
[10,11]. In 2004, Chakraborti et al. [12] demonstrated that
the efﬁciency of these methods is dependent on the use of
highly electrophilic carbonyl compounds and strongly nucleo-
philic amines. They proposed as an alternative the use of sub-
stances that function as Bro¨nsted-Lowry or Lewis acids to
activate the carbonyl group of aldehydes, catalyze the nucleo-
philic attack by amines, and dehydrate the system, eliminating
water as the ﬁnal step [12]. Examples of Bro¨nsted-Lowry or le-
wis acids used for the synthesis of Schiff bases include ZnCl2,
TiCl4, MgSO4-PPTS, Ti(OR)4, alumina, H2SO4, NaHCO3,
MgSO4, Mg(ClO4)2, H3CCOOH, Er(OTf)3, P2O5/Al2O3, HCl
[12–24].
In the past 12 years a number of innovations and new tech-
niques have been reported, including solvent-free/clay/micro-
wave irradiation, solid-state synthesis, K-10/microwave,
water suspension medium, [bmim]BF4/molecular sieves, infra-
red irradiation/no solvent, NaHSO4ÆSiO2/microwave/solvent-
free, solvent-free/CaO/microwave, and silica/ultrasound irra-
diation [25–33]. Among these innovations, microwave irradia-
tion has been extensively used due to its operational simplicity,
enhanced reaction rates, and great selectivity [32]. The use of
microwave irradiation commenced with the independent stud-
ies of Rousell and Majetich groups [34,35]. Microwave irradi-
ation is less environmentally problematic than other methods
because it abolishes the excessive use of aromatic solvents
and the Dean-Stark apparatus for azeotropic removal of
water. Another feature of this technique is that the reactions
achieve high efﬁciency in a shorter period of time.Biological activities of schiff bases
Antimalarial activity
Malaria is a neglected disease that still causes serious public
health problems. Every year, approximately 500 million people
are afﬂicted by the disease, of whom around 1–3 million die,
90% of who in sub-Sahara Africa are primarily children [36].
Malaria is currently found in more than 100 countries
throughout Africa, Latin America, Asia, and Oceania. Human
malaria is mainly caused by four species of Plasmodium (P. fal-
ciparum, P. vivax, P. ovale, and P. malariae). The female mos-
quito of the Anopheles genus is the vector of Plasmodium [37].The search for new drugs, vaccines, and insecticides to prevent
or treat this disease is clearly a priority.
Schiff bases have been shown to be interesting moieties for
the design of antimalarial agents. Ancistrocladidine (1; Fig. 2)
is a secondary metabolite produced by plants from the families
Ancistrocladaceae and Dioncophyllaceae that present an imine
group in its molecular scaffold. Compound 1 has been shown
to be active against P. falciparum K1 and 3D7. The minimum
inhibitory concentrations (MIC values) of ancistrocladidine
necessary to completely abolish P. falciparum K1 and 3D7
growth were 0.3 and 1.9 lg/mL, respectively. Interestingly,
compound 1 was 90- and 10-fold more selective to P. falcipa-
rum K1 and 3D7,respectively than to rat skeletal myoblast
L-6 cells [4]. Rathelot et al. [38] described the synthesis of
Schiff base-functionalised 5-nitroisoquinolines and investi-
gated the in vitro activity of these compounds against an
ACC Niger chloroquine resistant P. falciparum strain. Schiff
base 5 (Fig. 3) was the most effective antimalarial agent among
the synthesised 5-nitroisoquinoline derivatives. The concentra-
tion of compound 5 necessary to inhibit P. falciparum growth
by 50% (IC50) was 0.7 lg/mL. Under the same experimental
conditions the IC50 value for chloroquine was 0.1 lg/mL [38].
Antibacterial activity
The increase in the mortality rate associated with infectious
diseases is directly related to bacteria that exhibit multiple
resistance to antibiotics. The lack of effective treatments is
the main cause of this problem [39,40]. The development of
new antibacterial agents with novel and more efﬁcient mecha-
nisms of action is deﬁnitely an urgent medical need [41].
Schiff bases have been pointed to as promising antibacterial
agents. For example, N-(salicylidene)-2-hydroxyaniline (4;
Fig. 2) is effective against Mycobacterium tuberculosis
H37Rv, exhibiting an MIC value of 8 lg/mL [5]. The selectiv-
ity of compound 4 was checked by performing experiments
with J774 macrophages. No cytotoxic effect on J774 macro-
phages was observed for compound 4, even when it was tested
at concentrations as high as 1000 lg/mL. More than 80% of
macrophage cells were viable at such experimental conditions,
demonstrating the high selectivity of compound 4.
The synthesis and antimicrobial activity of a series of Schiff
bases derived from the condensation of 5-chloro-salicylalde-
hyde and primary amines has recently been reported [42].
The 5-chloro-salicylaldehyde-Shiff base derivatives 6–15
(Fig. 3) were most active against at least one of the evaluated
bacterial species. Pseudomonas ﬂuorescence was the strain most
sensitive to compounds 6–11 and 13–15, with MIC values
ranging from 2.5 to 5.2 lg/mL. The MIC value for the refer-
ence drug kanamycin against the same bacterial strain was
3.9 lg/mL. The Schiff bases 6, 7, 9–11, 14, and 15 presented
MIC values in the range of 1.6–5.7 lg/mL against Escherichia
coli, while the MIC value for kanamycin was 3.9 lg/mL. Bacil-
lus subtilis was sensitive to the Schiff base 14 only
(MIC = 1.8 lg/mL). The MIC values for compounds 6 and
7 against Staphylococcus aureus were, respectively, 3.1 and
1.6 lg/mL [42].
Isatin-derived Schiff bases have also been reported to pos-
sess antibacterial activity [43]. Twenty-eight bacteria of clinical
interest were used in the studies performed by Pandeya and
colleagues. The authors disclosed the isatin-derived Schiff base
16 (Fig. 3) as the most potent compound amongst those syn-
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Fig. 2 Examples of bioactive Schiff bases. The imine or azomethine group present in each molecular structure is shaded.
Biological activities of Schiff bases 3thesised against all the pathogenic bacteria studied. The MIC
values for compound 16 against E. coli NCTC 10418, Vibrio
cholerae non-01, Enterococcus faecalis, Proteus shigelloides
were 2.4, 0.3, 1.2, and 4.9 lg/mL, respectively, while the
MIC values for sulfamethoxazole (reference drug) against the
same bacterial strains were in the range of 312–5000 lg/mL.
Thus compound 16 was notably 1040-, 1040-, 4160-, and
1020-fold more potent than sulphamethoxazole. Other isatin-
derived Schiff bases have been described in the literature, but
with no expressive antibacterial activities [44,45].
The isoniazid-derived Schiff base 17 (Fig. 3) was active
against M. tuberculosis H37Rv, exhibiting an MIC value of
0.03 mg/L [46]. In this respect, compound 17 was slightly more
potent than isoniazid, its immediate synthetic precursor. Addi-
tionally, the isoniazid-derived Schiff base 17 was not toxic
against the cell line VERO (epithelial cells from healthy mon-
key kidney). The IC50 for compound 17 against VERO cells
was as high as 1 g/mL, indicating that this isoniazid-derived
Schiff base is selective for bacterial cells. The therapeutic safety
and effectiveness for compound 17 is higher than 40,000, mak-
ing this Schiff base an excellent lead for the development of
antitubercular agents [46].
In 2005, Panneerselvam et al. [21] described the synthesis
and in vitro antibacterial activity of eleven morpholine-derived
Schiff bases. Fig. 3 shows the chemical structure of three of
them (compounds 18–20). The authors found that S. aureus
and Micrococcus luteus were the bacteria most sensitive to
the morpholine-derived Schiff base 18 (MIC = 20 and 32 lg/
mL, respectively). Streptococcus epidermidis was more sensitive
to the morpholine-derived Schiff base 19 (MIC = 17 lg/mL)
and Bacillus cereus and E. coli were more sensitive to com-
pound 20 (MIC = 21 and 16 lg/mL, respectively).
Schiff bases with a 2,4-dichloro-5-ﬂuorophenyl moiety are
also effective in the inhibition of bacterial growth. Schiff bases
from this class (compounds 21–24 in Fig. 3) completely inhib-
ited the growth of S. aureus, E. coli, Pseudomonas aeruginosa,
and Klebsiella pneumoniae [47]. MIC values for these com-
pounds varied from 6.3 to 12.5 lg/mL, which are comparable
to those obtained for the reference drug ciproﬂoxacin [47].
Madurahydroxylactone Schiff bases are imines derived
from natural products. Madurahydroxylactones are secondary
metabolites produced by the plant Actinomadura rubra [48].
The imines 25–30 (Fig. 4) are examples of Schiff bases belong-ing to this class. With the exception of compounds 25 and 30,
all madurahydroxylactone-derived compounds were effective
in the in vitro inhibition of B. subtilis, Micrococcus ﬂavus, Sar-
cina lutea, and S. aureus growth, with MIC values varying
from 0.2 to 3.1 lg/mL [49]. These same compounds (26–29)
presented very low activity against Mycobacterium phlei or
Proteus vulgaris (MIC values higher than >50.0 lg/mL) [49].
Other molecules of natural or non-natural origin that are
platforms for the synthesis of Schiff bases for antibacterial
activities include amino acids, coumarins, sulfonamides, or res-
acetophenones, aminothiazolyl bromocoumarins, crown
ethers, O-phthaldehyde, or 2-aminophenol and 1,2,4-triazoles
[24,50–56]. The antibacterial property of compounds represen-
tative of these classes was examined. However, they did not ex-
hibit any notable activity.
Antifungal activity
Fungal infections are not usually limited to the superﬁcial tis-
sues; indeed, a signiﬁcant increase in life threatening systemic
fungal infections has been reported [57]. The fundamental rea-
son for this is the increasing number of patients at risk, including
those with advanced age, major surgery, immunosuppressive
therapy, acquired immunodeﬁciency syndrome (AIDS), cancer
treatment, and solid-organ and hematopoietic stem cell trans-
plantation [58]. The search and development of more effective
antifungal agents are mandatory [59,60] and some Schiff bases
are known to be promising antifungal agents.
Alternaria brassicae and Alternaria brassicicola are phyto-
pathogenic fungi that severely affect the production of most
cruciferous crops (broccoli, cauliﬂower, mustard, turnip, cab-
bage, rape, and radish). N-(Salicylidene)-2-hydroxyaniline 4
(Fig. 2) at the concentration of 500 ppm inhibited the growth
of these fungi by 67–68% [61]. Compounds 2 and 3 (Fig. 2)
are examples of chitosan-derived Schiff bases with antifungal
activity. They inhibited the growth of Botrytis cinerea and Col-
letotrichum lagenarium by 26–33% and 35–38% when used at
1000 ppm, respectively [6]. Overall, studies evaluating the ef-
fect of Schiff bases on phytopathogenic fungal growth have
been modest and deserve more investigation.
Schiff bases with a 2,4-dichloro-5-ﬂuorophenyl moiety, such
as compounds 21 (Fig. 3) and 31–34 (Fig. 5) have been demon-
strated to inhibit the growth of fungi of clinical interest, such as
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Fig. 3 Chemical structure of some synthetic antibacterial Schiff bases. *Compound 5 is an antimalarial agent.
4 C.M. da Silva et al.Aspergillus fumigatus, Aspergillus ﬂavus, Trichophyton ment-
agrophytes, and Penicillium marneffei. The MIC values for
these compounds were in the range of 6.3–12.5 lg/mL, indicat-
ing that they are as potent as the reference ﬂuconazole [47].
Piperonyl-derived Schiff bases (35–40, Fig. 5) were active
against some fungi at micromolar concentrations. They inhib-
ited the growth of Trichophyton rubrum (MIC = 820–980 lM)
and Epidermophyton ﬂoccosum (MIC = 200–930 lM) [62].
The isatin-derived Schiff bases 16 (Fig. 3) and 41–51 (Fig. 5)
were considerably active against Microsporum audouinii
(MIC values ranging from 2.4 to 9.7 lg/mL) andMicrosporum
gypseum (MIC values ranging from 1.2 to 9.7 lg/mL) [43].
Compounds 16 and 41–51 also inhibited the growth of Can-
dida albicans, Aspergillus niger, Cryptococcus neoformans, T.
mentagrophytes, E. ﬂoccosum, and Histoplasma capsulatum at
MIC values higher than 10 lg/mL and lower than 79 lg/mL
[43]. In another study, Panneerselvam et al. [21] showed that
the growth of both C. albicans and A. niger was compromisedby treatment with compound 20 (Fig. 3) at 20 lg/mL or com-
pound 52 (Fig. 5) at 30 lg/mL.
As for antibacterial activity, natural product-derived Schiff
bases are also promising for the design of new antifungal
agents. Domb and colleagues have described an interesting ap-
proach to synthesize a nystatin-dextran-derived Schiff base
(53, Fig. 5). This approach dramatically improved nystatin sol-
ubility in water [63]. Compound 53 completely inhibited the
growth of C. albicans and C. neoformans at 20 lg/mL, while
a concentration of 10 lg/mL was required for free nystatin
to have a similar effect. Although the nystatin-dextran-derived
Schiff base 53 was less active than nystatin itself, the former
was shown to be much less toxic to normal cells [63].
Antiviral activity
The use of vaccines may lead to the eradication of viral patho-
gens, such as smallpox, polio, and rubella. However, virus-re-
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6 C.M. da Silva et al.lated and hepatitis C human immunodeﬁciency diseases have
been the drawback of vaccine approaches [64]. Viral diseases
are life-threatening for immunocompromised patients and a
prompt treatment is required to overcome this problem.
Although there are many therapeutic options for viral infec-
tions, currently available antiviral agents are not yet fully
effective, probably due to the high rate of virus mutation. They
may also present any of a number of side effects.
Salicylaldehyde Schiff bases of 1-amino-3-hydroxyguani-
dine tosylate are a good platform for the design of new antivi-
ral agents [65,66]. In fact, from a set of different 1-amino-3-
hydroxyguanidine tosylate-derived Schiff bases, compound
54 (Fig. 6) was shown to be very effective against mouse hep-
atitis virus (MHV), inhibiting its growth by 50% when em-
ployed at concentrations as low as 3.2 lM [66].
Recently, Sriram and colleagues [66] reported the synthesis
and antiviral activity of the abacavir-derived Schiff bases 55–
65 (Fig. 6). These compounds are a new series of abacavir pro-
drugs. Abacavir is a nucleoside analogue capable of inhibiting
the activity of reverse transcriptase. It is used to treat human
immunodeﬁciency virus (HIV) and AIDS, and is available un-
der the trade name Ziagen (GlaxoSmithKline). Compounds
55–65were signiﬁcantly effective against the human immunode-
ﬁciency virus-type 1 (HIV-1). The effective concentration
(EC50) of these abacavir-derived Schiff bases necessary to
achieve 50% protection of human leukemic cells (CEM) against
the cytopathic effect of HIV-1 was lower than 6 lM [66]. Nota-
bly, compound 57 was the most potent Schiff base, being effec-
tive at 50 nM. This compound is only toxic to CEM cells at
concentrations higher than 100 lM, indicating its potential as
a lead compound for the design of new anti-HIV-1 [66].
Concluding remarks
Schiff bases have been widely explored for industrial applica-
tions. However, the biological activity of this class of com-
pounds deserves further investigation. This becomes clear
when plant pathogens are considered. Although the research
on this subject is incipient, a number of reports disclosing
the effects of the Schiff bases on the pathogens of clinical inter-
est have recently been increasing. Schiff base compounds have
been shown to be promising leads for the design of more efﬁ-cient antimicrobial agents. Advances in this ﬁeld will require
analyses of the structure–activity relationships of the Schiff
bases as well as the mechanism of action of these compounds.Acknowledgements
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